Cargando…
Nanoparticles-based anti-aging treatment of Alzheimer’s disease
Age is the strongest risk factor for Alzheimer’s disease (AD). In recent years, the relationship between aging and AD has been widely studied, with anti-aging therapeutics as the treatment for AD being one of the mainstream research directions. Therapeutics targeting senescent cells have shown impro...
Autores principales: | Chu, Jian-Jian, Ji, Wen-Bo, Zhuang, Jian-Hua, Gong, Bao-Feng, Chen, Xiao-Han, Cheng, Wen-Bin, Liang, Wen-Danqi, Li, Gen-Ru, Gao, Jie, Yin, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302016/ https://www.ncbi.nlm.nih.gov/pubmed/35850622 http://dx.doi.org/10.1080/10717544.2022.2094501 |
Ejemplares similares
-
Biomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease
por: Chu, Jianjian, et al.
Publicado: (2023) -
Hydrogel: A Promising New Technique for Treating Alzheimer’s Disease
por: Gong, Baofeng, et al.
Publicado: (2022) -
The Long and the Short of Current Nanomedicines for Treating Alzheimer's Disease
por: Gong, Baofeng, et al.
Publicado: (2023) -
Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy
por: Yin, Tong, et al.
Publicado: (2023) -
Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease
por: Yin, Tong, et al.
Publicado: (2023)